Menu Search
Equities

Kimia Farma Tbk PT

KAEF:JKT

Kimia Farma Tbk PT

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (IDR)600.00
  • Today's Change-5.00 / -0.83%
  • Shares traded285.50k
  • 1 Year change-19.46%
  • Beta-0.1191
Data delayed at least 10 minutes, as of Nov 15 2024 09:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in IDRIncome statement in IDRView more

Year on year Kimia Farma Tbk PT had net income fall 679.93% from a loss of 190.47bn to a larger loss of 1.49tn despite a 7.93% increase in revenues from 9.23tn to 9.97tn. An increase in the cost of goods sold as a percentage of sales from 59.59% to 70.95% was a component in the falling net income despite rising revenues.
Gross margin24.05%
Net profit margin-21.98%
Operating margin-19.86%
Return on assets-11.90%
Return on equity-25.56%
Return on investment-23.42%
More ▼

Cash flow in IDRView more

In 2023, cash reserves at Kimia Farma Tbk PT fell by 1.36tn. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 364.58bn for operations while cash used for investing totalled 722.50bn.
Cash flow per share-292.11
Price/Cash flow per share--
Book value per share957.72
Tangible book value per share927.39
More ▼

Balance sheet in IDRView more

Kimia Farma Tbk PT has a Debt to Total Capital ratio of 57.02%, a higher figure than the previous year's 13.61%.
Current ratio0.6759
Quick ratio0.4154
Total debt/total equity1.42
Total debt/total capital0.5702
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.